CD47 and cancer: We used CRISPR-modified HAP1 cells, which are commonly used for loss of function genetic screens47,48, transduced as reported previously49 with Cas9 and a single-guide RNA (sgRNA) targeting CD47, a cell surface protein responsible for immune evasion in cancer.